Kneat.com (KSI.TO)

Friday

11:02 PM

ThesisKneat.com: the setup is constructive — New customer wins, particularly Fortune 500 pharma/biotech logos that validate platform credibility

Revenue Outlook

Metric	FY2025	FY2026E	FY2027E
Revenue	$63M	$79M	$98M
Rev. Growth	+29.3%	+24.2%	+24.1%
EPS	$-0.02	$-0.09	$0.01
EPS Growth	+72.3%	-277%	+116%
P/E (fwd)	—	—	442.2×

★ Analysts see FY2026 revenue reaching $79M — +24.2% growth in a single year.

Why Revenue Could Accelerate

01New customer wins, particularly Fortune 500 pharma/biotech logos that validate platform credibility
02Annual recurring revenue (ARR) growth rate and net revenue retention metrics indicating customer expansion
03Quarterly subscription revenue growth acceleration or deceleration vs. 40%+ baseline expectations
04Path to profitability milestones - operating cash flow breakeven is critical inflection point for valuation re-rating
05Competitive threats from larger enterprise software vendors (Veeva, MasterControl) entering validation management space

FY2025 Snapshot

Revenue: $63M
Rev. Growth: +29.3%
Gross Margin: 54.9%
Op. Margin: -13.4%
Net Margin: -3.7%
Net Income: $-2M
NI Growth: +69.6%
EPS: $-0.02
1Y Return: +10.5%

KSI.TO Chart

My Notes

growth - Investors are paying 6.5x sales for 43% revenue growth in a niche, defensible market.
Rising rates create multiple headwinds: (1) Valuation compression - high-growth…
Watch on earnings: Pharmaceutical industry R&D spending trends (proxy for IT budget availability), FDA 483 inspection citations and warning letters (increased regulatory scrutiny drives validation software demand), Biotech IPO and venture funding volumes (leading indicator of new customer pipeline).

One Sentence Summary:

The bull case is simple: analysts see revenue climbing from $79M to $98M as new customer wins, particularly fortune 500 pharma/biotech logos that validate platform credibility.

Auto-composed from Stock Alarm intelligence, financial statements, and analyst estimates. Not investment advice.

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance